HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma

NCT07685535 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer

Interventions

DEVICE: DEB-TACE
DRUG: Toripalimab
DRUG: Lenvatinib
DRUG: Gemcitabine
DRUG: Oxaliplatin

Sponsor

Shanghai Zhongshan Hospital